Evidence map›Paper›PMID 39379355›Full record

ArticleTranslational psychiatry2024

Importin α4 deficiency induces psychiatric disorder-related behavioral deficits and neuroinflammation in mice.

Koki Sakurai, Makiko Morita, Yoshiatsu Aomine, Mitsunobu Matsumoto, Tetsuji Moriyama, Emiko Kasahara, Atsuo Sekiyama, Mayumi Otani, Rieko Oshima, Kate L Loveland and 5 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Koki SakuraiLaboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.ORCID 0000-0001-6952-7749
Makiko MoritaLaboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.
Yoshiatsu AomineLaboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan.ORCID 0009-0005-1569-8207
Mitsunobu MatsumotoDepartment of Preemptive Medical Pharmacology for Mind and Body, Graduate School and School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.
Tetsuji MoriyamaDepartment of Cell Biology and Biochemistry, Division of Medicine, School of Medical Sciences, University of Fukui, Eiheiji Cho, Fukui, Japan.
Emiko KasaharaDepartment of Preemptive Medical Pharmacology for Mind and Body, Graduate School and School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.ORCID 0009-0002-2952-0256
Atsuo SekiyamaDepartment of Preemptive Medical Pharmacology for Mind and Body, Graduate School and School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.
Mayumi OtaniLaboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan.
Rieko OshimaLaboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan.
Kate L LovelandCentre for Reproductive Health, Hudson Institute of Medical Research Wright St, Clayton, VIC, Australia.
Masami YamadaDepartment of Cell Biology and Biochemistry, Division of Medicine, School of Medical Sciences, University of Fukui, Eiheiji Cho, Fukui, Japan.
Yoshihiro YonedaThe Research Foundation for Microbial Diseases of Osaka University, Suita, Japan.
Masahiro OkaLaboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan. moka@biken.osaka-u.ac.jp.ORCID 0000-0003-0123-3060
Takatoshi HikidaLaboratory for Advanced Brain Functions, Institute for Protein Research, Osaka University, Suita, Osaka, Japan. hikida@protein.osaka-u.ac.jp.ORCID 0000-0002-8653-311X
Yoichi MiyamotoLaboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan. ymiyamoto@nibiohn.go.jp.ORCID 0000-0003-4016-1119

Funding

Japan Agency for Medical Research and Development (AMED) 21gm1510006Japan Agency for Medical Research and Development (AMED) 23ama121052Japan Agency for Medical Research and Development (AMED) JP21wm0425010Japan Agency for Medical Research and Development (AMED) JP23ama121054MEXT | Japan Science and Technology Agency (JST) JPMJSP2138MEXT | Japan Society for the Promotion of Science (JSPS) 16H04789MEXT | Japan Society for the Promotion of Science (JSPS) 17H03679MEXT | Japan Society for the Promotion of Science (JSPS) 20H03444MEXT | Japan Society for the Promotion of Science (JSPS) 23K27373MEXT | Japan Society for the Promotion of Science (JSPS) JP15K07068MEXT | Japan Society for the Promotion of Science (JSPS) JP20K06455MEXT | Japan Society for the Promotion of Science (JSPS) JP22H02944MEXT | Japan Society for the Promotion of Science (JSPS) JP22KK0111MEXT | Japan Society for the Promotion of Science (JSPS) JP23K18163Salt Science Research Foundation (SSRF) 2229
6 · The paper itself

Abstract

Importin α4, which is encoded by the Kpna4 gene, is a well-characterized nuclear-cytoplasmic transport factor known to mediate transport of transcription factors including NF-κB. Here, we report that Kpna4 knock-out (KO) mice exhibit psychiatric disorder-related behavioral abnormalities such as anxiety-related behaviors, decreased social interaction, and sensorimotor gating deficits. Contrary to a previous study predicting attenuated NF-κB activity as a result of Kpna4 deficiency, we observed a significant increase in expression levels of NF-κB genes and proinflammatory cytokines such as TNFα, Il-1β or Il-6 in the prefrontal cortex or basolateral amygdala of the KO mice. Moreover, examination of inflammatory responses in primary cells revealed that Kpna4 deficient cells have an increased inflammatory response, which was rescued by addition of not only full length, but also a nuclear transport-deficient truncation mutant of importin α4, suggesting contribution of its non-transport functions. Furthermore, RNAseq of sorted adult microglia and astrocytes and subsequent transcription factor analysis suggested increases in polycomb repressor complex 2 (PRC2) activity in Kpna4 KO cells. Taken together, importin α4 deficiency induces psychiatric disorder-related behavioral deficits in mice, along with an increased inflammatory response and possible alteration of PRC2 activity in glial cells.

Indexed as

alpha KaryopherinsBehavior, AnimalMice, KnockoutNeuroinflammatory DiseasesAnimalsAnxietyAstrocytesBasolateral Nuclear ComplexCytokinesDisease Models, AnimalMaleMental DisordersMiceMice, Inbred C57BLMicrogliaNF-kappa Balpha KaryopherinsCytokinesNF-kappa B

Identifiers

PMID39379355
PMCPMC11461878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.